FiberCon Interactions
There are 33 drugs known to interact with FiberCon (polycarbophil), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 7 are moderate, and 26 are minor.
- View all 33 medications that may interact with FiberCon
- View FiberCon alcohol/food interactions (1)
- View FiberCon disease interactions (5)
Most frequently checked interactions
View interaction reports for FiberCon (polycarbophil) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Colace (docusate)
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- melatonin
- metformin
- metoprolol
- MiraLAX (polyethylene glycol 3350)
- multivitamin
- omeprazole
- pantoprazole
- prednisone
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Synthroid (levothyroxine)
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
FiberCon alcohol/food interactions
There is 1 alcohol/food interaction with FiberCon (polycarbophil).
FiberCon disease interactions
There are 5 disease interactions with FiberCon (polycarbophil) which include:
- intestinal obstruction
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- hypercalcemia
More about FiberCon (polycarbophil)
- FiberCon consumer information
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Drug class: laxatives
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.